ColgatePalmolive (CL)
(Delayed Data from NYSE)
$90.77 USD
+0.55 (0.61%)
Updated Nov 7, 2024 03:59 PM ET
After-Market: $90.75 -0.02 (-0.02%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$90.77 USD
+0.55 (0.61%)
Updated Nov 7, 2024 03:59 PM ET
After-Market: $90.75 -0.02 (-0.02%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
Zacks News
Will Colgate-Palmolive (CL) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Colgate-Palmolive (CL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Demand & Pricing Trends Aid PepsiCo's (PEP) Q3 Earnings?
by Zacks Equity Research
PepsiCo's (PEP) Q3 results are expected to have gained from strong demand, improved pricing, strength in its beverage and food businesses, and gains from cost- and revenue-management initiatives.
What Awaits Conagra Brands (CAG) as It Queues for Q1 Earnings?
by Zacks Equity Research
Conagra Brands' (CAG) first-quarter results are likely to reflect gains from the frozen and snacks categories. Solid pricing efforts are likely to aid amid cost inflation.
P&G (PG) Gains From Solid Product Portfolio, Pricing Actions
by Zacks Equity Research
Procter & Gamble (PG) stays afloat in a tough environment, thanks to its product portfolio, pricing actions, and productivity and cost-saving plans.
Consumer Confidence Plummets on Recession Fears: 5 Stocks to Buy
by Ritujay Ghosh
Consumer confidence is declining on recession fears. Defensive stocks like ALLETE (ALE), Consolidated Water (CWCO), American Water Works Company (AWK), Kimberly-Clark (KMB) and Colgate-Palmolive (CL) are safe bets.
Will Colgate's (CL) Innovation Efforts Boost Its Stock?
by Zacks Equity Research
Colgate (CL) suffers from rising raw material costs and inflation, as well as the impacts of pricing actions. Its innovation and expansion efforts place it well for growth in the long term.
The Zacks Analyst Blog Highlights Visa, Chubb, HCA Healthcare, Colgate-Palmolive and Veeva
by Zacks Equity Research
Visa, Chubb, HCA Healthcare, Colgate-Palmolive and Veeva are included in this Analyst Blog.
Top Stock Reports for Visa, Chubb & HCA Healthcare
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), Chubb Limited (CB) and HCA Healthcare, Inc. (HCA).
Can Its Growth Efforts Aid Colgate (CL) Amid Cost Woes?
by Zacks Equity Research
Despite rising raw material costs and adverse currency, Colgate's (CL) robust innovation, pricing efforts and expansion plans are likely to drive growth in the long term.
The Zacks Analyst Blog Highlights Visa, Novo Nordisk, Medtronic, Shopify and Colgate-Palmolive
by Zacks Equity Research
Visa, Novo Nordisk, Medtronic, Shopify and Colgate-Palmolive are included in this Analyst Blog.
Top Stock Reports for Visa, Novo Nordisk & Medtronic
by Sheraz Mian
Today's Research Daily features new research reports on 12 major stocks, including Visa Inc. (V), Novo Nordisk A/S (NVO) and Medtronic plc (MDT).
Zacks Industry Outlook Highlights Unilever, Church & Dwight, Procter & Gamble and Colgate-Palmolive
by Zacks Equity Research
Unilever, Church & Dwight, Procter & Gamble and Colgate-Palmolive have been highlighted in this Industry Outlook article.
4 Soaps & Cleaning Materials Stocks to Gain as Industry Catches On
by Avisekh Bhattacharjee
The soap and cleaning materials industry benefits from revived demand trends, pricing actions, innovation, digital transformation and brand building. Players like UL, CHD, PG and CL look well-poised.
Colgate (CL) Q2 Earnings & Sales Surpass Estimates, View Up
by Zacks Equity Research
Colgate-Palmolive's (CL) second-quarter 2023 organic sales advance 8%, with improvements in all divisions and categories.
Procter & Gamble (PG) Rises on Q4 Earnings Beat, Robust View
by Zacks Equity Research
Procter & Gamble's (PG) Q4 results reflect strong gains from its pricing actions, robust demand, improved sales and margins, and a positive product mix.
Pre-Markets Rebound After Selloff; PCE & Q2 Numbers Everywhere
by Mark Vickery
Year over year PCE headline came down to +3.0%, +4.1% on core. Still above the Fed's optimum inflation rate, but well off cycle highs.
Core PCE Inflation Drops to 2 - Year Low
by Zacks Equity Research
Core PCE Inflation Drops to 2 - Year Low
Colgate-Palmolive (CL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Colgate-Palmolive (CL) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Colgate-Palmolive (CL) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Colgate-Palmolive (CL) delivered earnings and revenue surprises of 2.67% and 3.23%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Top-Rated Stocks to Watch as Earnings Approach
by Shaun Pruitt
Investors should pay attention to other sectors outside of Energy on Friday as there appears to be opportunity in these Consumer Staples and Auto sector stocks.
Should You Buy Colgate-Palmolive (CL) Ahead of Earnings?
by Zacks Equity Research
Colgate-Palmolive (CL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Factors to Note Ahead of Panasonic's (PCRFY) Q1 Earnings
by Zacks Equity Research
Amid macro-economic turmoil, Panasonic's (PCRFY) first-quarter fiscal 2024 performance is likely to have been cushioned by continued momentum in sales of A2W products in Europe.
Colgate (CL) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Colgate's (CL) second-quarter 2023 sales are likely to have benefited from strong demand for its products, innovation, brand strength and a focus on premiumization. Rising costs and expenses might have hurt its margins.
Clorox (CLX) Gains From Digital Initiatives & Pricing Power
by Zacks Equity Research
Clorox's (CLX) IGNITE strategy serves as a catalyst for driving innovation, enhancing operational efficiency and bolstering international growth.
Procter & Gamble (PG) Widens Spectrum on Value Creation
by Zacks Equity Research
Procter & Gamble (PG) advances the execution of the integrated strategies -- Supply Chain initiatives and digital penetration to strengthen the organization.